| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell morphogenesis | HEXB MAG ATP7A MAP1A NCKAP1 TPRN CDHR3 DAG1 SLIT2 FAT1 PTPRJ PTPRO UBE3A ULK1 KIF5C PLXNB3 ARAP1 ANK3 SEMA7A FRYL VPS54 SKIL CDH22 CELSR2 MAP1S PAFAH1B1 PLXNA4 IHH CTNND2 CDH13 | 1.34e-05 | 1194 | 222 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell projection assembly | GBF1 ATP7A NCKAP1 TOGARAM1 QRICH2 RCC2 CC2D2B SLIT2 CCDC66 KIF3B ALMS1 PTPRO KLF5 PLXNB3 ARAP1 DYNC2H1 WASHC1 ABLIM3 CELSR2 DNAAF1 CDH13 | 1.74e-05 | 685 | 222 | 21 | GO:0030031 |
| GeneOntologyBiologicalProcess | lamellipodium assembly | 2.29e-05 | 79 | 222 | 7 | GO:0030032 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | GBF1 ATP7A NCKAP1 TOGARAM1 RCC2 CC2D2B SLIT2 CCDC66 KIF3B ALMS1 PTPRO KLF5 PLXNB3 ARAP1 DYNC2H1 WASHC1 ABLIM3 CELSR2 DNAAF1 CDH13 | 4.03e-05 | 670 | 222 | 20 | GO:0120031 |
| GeneOntologyCellularComponent | cell leading edge | GBF1 ATP7A NCKAP1 PIEZO1 DAG1 LAMP5 ADGRV1 PTK6 DUOX1 FAT1 PTPRJ PTPRO WASHC1 GRIA2 ABLIM3 SH2B2 PAFAH1B1 GABRA6 | 8.08e-06 | 500 | 224 | 18 | GO:0031252 |
| GeneOntologyCellularComponent | dendritic branch | 4.12e-05 | 7 | 224 | 3 | GO:0044307 | |
| GeneOntologyCellularComponent | axon | MAG MAP9 SETX ATP7A IMPA1 MAP1A CDHR3 DAG1 LAMP5 SLIT2 KIF3B PTPRO C4A C4B ULK1 KIF5C ANK3 GRIA2 GRIN2B IGHMBP2 PAFAH1B1 SEPTIN11 PUM1 | 9.25e-05 | 891 | 224 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.00e-04 | 164 | 224 | 8 | GO:0098982 | |
| Domain | CA | 9.86e-06 | 115 | 223 | 9 | SM00112 | |
| Domain | Cadherin-like | 1.06e-05 | 116 | 223 | 9 | IPR015919 | |
| Domain | Cadherin | 1.22e-05 | 118 | 223 | 9 | IPR002126 | |
| Domain | Anaphylatoxin_comp_syst | 1.65e-05 | 5 | 223 | 3 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.65e-05 | 5 | 223 | 3 | IPR001840 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 5.31e-05 | 18 | 223 | 4 | IPR008930 | |
| Domain | ANATO | 5.67e-05 | 7 | 223 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 5.67e-05 | 7 | 223 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 5.67e-05 | 7 | 223 | 3 | PS01177 | |
| Domain | ANATO | 5.67e-05 | 7 | 223 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 5.67e-05 | 7 | 223 | 3 | IPR000020 | |
| Domain | CADHERIN_1 | 6.36e-05 | 113 | 223 | 8 | PS00232 | |
| Domain | Cadherin | 6.36e-05 | 113 | 223 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 6.77e-05 | 114 | 223 | 8 | PS50268 | |
| Domain | - | 6.77e-05 | 114 | 223 | 8 | 2.60.40.60 | |
| Domain | A2M | 1.89e-04 | 10 | 223 | 3 | PF00207 | |
| Domain | A2M_N_2 | 1.89e-04 | 10 | 223 | 3 | IPR011625 | |
| Domain | A2M_comp | 1.89e-04 | 10 | 223 | 3 | IPR011626 | |
| Domain | A2M_recep | 1.89e-04 | 10 | 223 | 3 | PF07677 | |
| Domain | A2M_comp | 1.89e-04 | 10 | 223 | 3 | PF07678 | |
| Domain | A2M_N | 1.89e-04 | 10 | 223 | 3 | PF01835 | |
| Domain | A2M_N | 1.89e-04 | 10 | 223 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.89e-04 | 10 | 223 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.89e-04 | 10 | 223 | 3 | PS00477 | |
| Domain | A2M_N_2 | 1.89e-04 | 10 | 223 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 1.89e-04 | 10 | 223 | 3 | IPR001599 | |
| Domain | Cadherin_CS | 3.35e-04 | 109 | 223 | 7 | IPR020894 | |
| Domain | - | 3.41e-04 | 12 | 223 | 3 | 1.50.10.20 | |
| Domain | MAP1 | 4.22e-04 | 3 | 223 | 2 | IPR026074 | |
| Domain | - | WDR81 DMXL1 WDR3 UTP15 TAF5 PLXNB3 DCAF13 SEMA7A GEMIN5 DCAF10 PAFAH1B1 PLXNA4 | 6.92e-04 | 333 | 223 | 12 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | WDR81 DMXL1 WDR3 UTP15 TAF5 PLXNB3 DCAF13 SEMA7A GEMIN5 DCAF10 PAFAH1B1 PLXNA4 | 7.29e-04 | 335 | 223 | 12 | IPR015943 |
| Domain | Tscrpt_reg_SKI_SnoN | 8.38e-04 | 4 | 223 | 2 | IPR023216 | |
| Domain | c-SKI_SMAD_bind | 8.38e-04 | 4 | 223 | 2 | PF08782 | |
| Domain | c-SKI_SMAD_bind | 8.38e-04 | 4 | 223 | 2 | SM01046 | |
| Domain | c-SKI_SMAD4-bd_dom | 8.38e-04 | 4 | 223 | 2 | IPR014890 | |
| Domain | - | 8.38e-04 | 4 | 223 | 2 | 1.20.91.20 | |
| Domain | C345C | 1.01e-03 | 17 | 223 | 3 | SM00643 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX GBF1 NCKAP1 MATR3 RBSN ALMS1 ZNF286B OSBPL10 KIF5C DOP1B CCSER1 TFEB ESYT1 CCDC85C FRYL SIK3 AKAP9 DCP1B IKBKE MAP4K1 AKAP13 RAI14 CEP152 CLINT1 EIF4G3 PUM1 | 1.20e-10 | 861 | 228 | 26 | 36931259 |
| Pubmed | HEXB MAG MAP9 DDAH1 MAP1A NCKAP1 MATR3 SCAPER OSBPL10 C4A C4B KIF5C PRKAG2 MTUS2 WNK2 PITPNM2 ANK3 COPB1 TNC GEMIN5 GRIA2 GRIN2B ABLIM3 PDHX MAP1S PAFAH1B1 PLXNA4 SEPTIN11 RAI14 CTNND2 EIF4G3 | 5.77e-09 | 1431 | 228 | 31 | 37142655 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GBF1 PIEZO1 ADGRB2 BCL9 PRR12 FAT1 ULK1 WNK2 ABCC10 ARAP1 DOCK3 PITPNM2 TFEB SEMA7A ESYT1 GEMIN5 FRYL SH2B2 MYOF CELSR2 GAREM2 MAP1S BTBD7 HELZ2 AKAP13 PUM1 | 2.13e-08 | 1105 | 228 | 26 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | GBF1 MAP1A BCL9 KLF5 WNK2 ARAP1 DOCK3 ANK3 TEX14 CCDC141 MAP1S MAP4K1 AKAP13 CLINT1 EIF4G3 | 1.93e-07 | 430 | 228 | 15 | 35044719 |
| Pubmed | GBF1 RC3H1 TOGARAM1 WAC PRR12 PARP4 ALMS1 SCAPER ZNF286B CCSER1 DOCK3 DYNC2H1 ABLIM3 MYOF HELZ2 CEP152 | 1.98e-07 | 493 | 228 | 16 | 15368895 | |
| Pubmed | Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity. | 2.78e-07 | 3 | 228 | 3 | 8649451 | |
| Pubmed | SETX RCC2 PRR12 PHKA2 FREM2 PARP4 CARD6 OSBPL10 C4A C4B ULK1 DNA2 RALGDS TCF12 SIK3 SMARCC1 AKAP13 CWF19L1 | 3.51e-07 | 650 | 228 | 18 | 38777146 | |
| Pubmed | Impaired mast cell-dependent natural immunity in complement C3-deficient mice. | 1.11e-06 | 4 | 228 | 3 | 9367154 | |
| Pubmed | Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first. | 1.11e-06 | 4 | 228 | 3 | 8015436 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCKAP1 SRM DAG1 TMEM214 SLIT2 UBE3A RABGGTB COPB1 ADAMTS1 INTS7 DYNC2H1 ESYT1 SGSH AHCTF1 CPD CACHD1 DHRS7B DHRS7 CLINT1 EIF4G3 PUM1 | 1.24e-06 | 942 | 228 | 21 | 31073040 |
| Pubmed | HEXB NR2C1 TRAF6 WAC WDR3 UBE3A KIF5C MTUS2 PLXNB3 DOP1B DOCK3 ANK3 RCAN1 COPB1 ADAMTS1 CACHD1 VPS54 GRIN2B SKIL MAP1S PSMG1 RAI14 CTNND2 EIF4G3 REPS2 | 1.38e-06 | 1285 | 228 | 25 | 35914814 | |
| Pubmed | NCKAP1 MATR3 ADGRB2 WDR81 BCL9 KIF3B UBE3A KIF5C TAF5 WNK2 NOP56 ANK3 GRIA2 GRIN2B SIK3 ABLIM3 AKAP9 CELSR2 SMARCC1 SEPTIN11 CTNND2 | 1.76e-06 | 963 | 228 | 21 | 28671696 | |
| Pubmed | RC3H1 CHI3L2 PTK6 DMXL1 MMP24 ACSM3 KIF3B KCNA10 STK39 ULK1 TAF5 WNK2 CARS1 CPD SIK3 MTMR7 MAP4K1 PAFAH1B1 | 1.83e-06 | 730 | 228 | 18 | 34857952 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | RC3H1 MATR3 TMEM214 BCL9 MIDEAS PRR12 PARP4 NOC4L AHCTF1 DCP1B DHRS7 SMARCC1 ITPRIP PUM1 | 2.29e-06 | 457 | 228 | 14 | 32344865 |
| Pubmed | 2.75e-06 | 5 | 228 | 3 | 15192652 | ||
| Pubmed | 2.75e-06 | 5 | 228 | 3 | 17200182 | ||
| Pubmed | Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency. | 2.75e-06 | 5 | 228 | 3 | 25039245 | |
| Pubmed | Formation of high affinity C5 convertase of the classical pathway of complement. | 2.75e-06 | 5 | 228 | 3 | 12878586 | |
| Pubmed | Predominant role for C5b-9 in renal ischemia/reperfusion injury. | 2.75e-06 | 5 | 228 | 3 | 10811844 | |
| Pubmed | HEXB ATP7A DAG1 TMEM214 BCL9 RCC2 KIAA1143 WAC SLIT2 RBSN PMPCA RADX ESYT1 AHCTF1 CCDC85C CPD CACHD1 VPS54 DHRS7 CLINT1 CWF19L1 | 3.51e-06 | 1007 | 228 | 21 | 34597346 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GBF1 MATR3 TOGARAM1 F5 FAT1 DOCK3 ANK3 GEMIN5 MAP1S DCAF10 AKAP13 CTNND2 | 5.39e-06 | 361 | 228 | 12 | 26167880 |
| Pubmed | 5.48e-06 | 6 | 228 | 3 | 32511263 | ||
| Pubmed | 5.48e-06 | 6 | 228 | 3 | 16849499 | ||
| Pubmed | 5.48e-06 | 6 | 228 | 3 | 2137109 | ||
| Pubmed | GBF1 ATP7A WDR81 TMEM214 DMXL1 RBSN OSBPL10 DOP1B ESYT1 WASHC1 CPD DHRS7 RAI14 VPS13B | 7.01e-06 | 504 | 228 | 14 | 34432599 | |
| Pubmed | 7.49e-06 | 151 | 228 | 8 | 17043677 | ||
| Pubmed | Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. | 9.55e-06 | 7 | 228 | 3 | 14660741 | |
| Pubmed | HEXB GBF1 ATP7A MATR3 F5 PARP4 KIF3B NRAS NOP56 COPB1 ESYT1 GEMIN5 CPD DHRS7B DCP1B MAP4K1 DHRS7 IGHMBP2 HELZ2 ITPRIP AKAP13 CLINT1 | 1.02e-05 | 1168 | 228 | 22 | 19946888 | |
| Pubmed | DMXL1 WAC UTP15 UBP1 TAF5 CARS1 GEMIN5 SMARCC1 AKAP13 RAI14 PUM1 | 1.49e-05 | 335 | 228 | 11 | 15741177 | |
| Pubmed | 1.52e-05 | 8 | 228 | 3 | 24474777 | ||
| Pubmed | 1.52e-05 | 8 | 228 | 3 | 28301559 | ||
| Pubmed | The role of complement in cryoglobulin-induced immune complex glomerulonephritis. | 1.52e-05 | 8 | 228 | 3 | 16272350 | |
| Pubmed | HEXB SETX NCKAP1 SRM WDR3 FAT1 NOC4L ULK1 DCTPP1 RABGGTB DCAF13 NOP56 ESYT1 CARS1 GEMIN5 CPD MYOF MAP1S PSMG1 PAFAH1B1 SEPTIN11 AKAP13 RAI14 | 1.66e-05 | 1297 | 228 | 23 | 33545068 | |
| Pubmed | TDRD15 SETX ATP7A DMXL1 WDR3 RBSN FAT1 OSBPL10 TCF12 ANK3 COPB1 ESYT1 MUC16 RAI14 CLINT1 EIF4G3 SLC25A19 | 1.68e-05 | 777 | 228 | 17 | 35844135 | |
| Pubmed | ATP7A PIEZO1 PBDC1 SRM TMEM214 DMXL1 WDR3 PMPCA UTP15 NOC4L DNA2 DCAF13 NOP56 ANK3 DYNC2H1 ESYT1 AHCTF1 CPD SIK3 PDHX AKAP9 DHRS7 AKAP13 EIF4G3 VPS13B | 1.71e-05 | 1487 | 228 | 25 | 33957083 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | MATR3 F5 RCC2 DMXL1 PRR12 SLIT2 UBP1 MTUS2 PITPNM2 SEMA7A INTS7 WASHC1 KANK4 | 1.75e-05 | 475 | 228 | 13 | 31040226 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | MAP1A NCKAP1 ADGRB2 PITPNM2 ANK3 PPM1E GRIA2 GRIN2B SIK3 CTNND2 | 1.85e-05 | 281 | 228 | 10 | 28706196 |
| Pubmed | 1.94e-05 | 225 | 228 | 9 | 12168954 | ||
| Pubmed | 2.07e-05 | 126 | 228 | 7 | 16284245 | ||
| Pubmed | IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. | 2.27e-05 | 9 | 228 | 3 | 21813773 | |
| Pubmed | EPC2 NR2C1 RC3H1 MATR3 BCL9 MIDEAS RCC2 PRR12 FAT1 ALMS1 KLF5 NOC4L TAF5 TCF3 TCF12 NOP56 COPB1 RADX CCDC85C DCP1B SMARCC1 RAI14 CEP152 PUM1 | 2.59e-05 | 1429 | 228 | 24 | 35140242 | |
| Pubmed | MAG NCKAP1 ADGRB2 ADGRV1 STK39 TNC GRIA2 ABLIM3 DHRS7B SEPTIN11 RAI14 REPS2 | 3.05e-05 | 430 | 228 | 12 | 32581705 | |
| Pubmed | Dengue hemorrhagic fever is associated with polymorphisms in JAK1. | 3.11e-05 | 91 | 228 | 6 | 20588308 | |
| Pubmed | 3.23e-05 | 10 | 228 | 3 | 30429287 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 3.31e-05 | 92 | 228 | 6 | 15840729 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | TRADD RCC2 FREM2 ALMS1 NOC4L KIF5C INTS7 DYNC2H1 PAFAH1B1 DNAAF1 | 3.41e-05 | 302 | 228 | 10 | 30561431 |
| Pubmed | Downregulation of E Protein Activity Augments an ILC2 Differentiation Program in the Thymus. | 4.28e-05 | 2 | 228 | 2 | 28258196 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 19062096 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 4.28e-05 | 2 | 228 | 2 | 17645767 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 4.28e-05 | 2 | 228 | 2 | 27758680 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 10958665 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 20154672 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 4.28e-05 | 2 | 228 | 2 | 3037333 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 11726230 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 4216347 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 4.28e-05 | 2 | 228 | 2 | 8428773 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 4.28e-05 | 2 | 228 | 2 | 21345967 | |
| Pubmed | E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. | 4.28e-05 | 2 | 228 | 2 | 17442955 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 2302180 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 22151770 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 29080553 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 4.28e-05 | 2 | 228 | 2 | 25339671 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 17728371 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 6149580 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 6149581 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 3542363 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 2387317 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 7365238 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 17971360 | ||
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 4.28e-05 | 2 | 228 | 2 | 17971229 | |
| Pubmed | The Menkes copper transporter is required for the activation of tyrosinase. | 4.28e-05 | 2 | 228 | 2 | 11092760 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 35898513 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 28873507 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 38839978 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 3794341 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 22785613 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 4.28e-05 | 2 | 228 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 4.28e-05 | 2 | 228 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 4.28e-05 | 2 | 228 | 2 | 7373044 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 4.28e-05 | 2 | 228 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 4.28e-05 | 2 | 228 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 4.28e-05 | 2 | 228 | 2 | 15787745 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 30026462 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 6559257 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 12480675 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 26800705 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 35816776 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 4.28e-05 | 2 | 228 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 4.28e-05 | 2 | 228 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 4.28e-05 | 2 | 228 | 2 | 3624865 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 31216032 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 30041577 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 4.28e-05 | 2 | 228 | 2 | 3862104 | |
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 4.28e-05 | 2 | 228 | 2 | 26814963 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 32817168 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 8132550 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 2395880 | ||
| GeneFamily | UPF1 like RNA helicases | 1.11e-08 | 11 | 139 | 5 | 1169 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.61e-05 | 9 | 139 | 3 | 1234 | |
| GeneFamily | WD repeat domain containing | 1.96e-04 | 262 | 139 | 9 | 362 | |
| GeneFamily | SKI transcriptional corepressors | 3.49e-04 | 4 | 139 | 2 | 748 | |
| GeneFamily | Phosphoinositide phosphatases | 1.87e-03 | 32 | 139 | 3 | 1079 | |
| GeneFamily | Plexins | 2.04e-03 | 9 | 139 | 2 | 683 | |
| GeneFamily | Complement system|Sushi domain containing | 2.64e-03 | 36 | 139 | 3 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 2.85e-03 | 37 | 139 | 3 | 454 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX GBF1 NCKAP1 TOGARAM1 SLIT2 FAT1 UBE3A STK39 KIF5C DOP1B UBR2 TCF12 AHCTF1 FRYL SIK3 ABLIM3 MYOF AKAP9 PAFAH1B1 AKAP13 CLINT1 EIF4G3 PUM1 VPS13B | 4.78e-07 | 856 | 227 | 24 | M4500 |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | ATP7A ZGRF1 ADGRB2 MIDEAS CISH UBP1 DYNC2H1 HELZ2 AKAP13 CTNND2 | 1.04e-05 | 200 | 227 | 10 | M291 |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 1.94e-05 | 131 | 227 | 8 | MM1127 | |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 2.47e-05 | 221 | 227 | 10 | M15835 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | RNF19B NR4A1 CISH CSRNP1 KLF5 C4A C4B RALGDS RCAN1 ADAMTS1 FRYL SKIL | 2.67e-05 | 322 | 227 | 12 | MM3786 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | DAG1 PARP4 PMPCA C4B ULK1 ABCC10 DOP1B UBR2 TCF3 ESYT1 CELSR2 | 3.15e-05 | 276 | 227 | 11 | M3063 |
| Coexpression | GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP | 3.55e-05 | 22 | 227 | 4 | M7184 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 4.98e-05 | 110 | 227 | 7 | M1309 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 5.20e-05 | 194 | 227 | 9 | M2517 | |
| Coexpression | GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP | 5.41e-05 | 195 | 227 | 9 | M9873 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 6.33e-05 | 199 | 227 | 9 | M8606 | |
| Coexpression | GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN | 6.33e-05 | 199 | 227 | 9 | M6928 | |
| Coexpression | GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP | 6.58e-05 | 200 | 227 | 9 | M7022 | |
| Coexpression | GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN | 6.58e-05 | 200 | 227 | 9 | M6442 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | SETX INPP5A F5 TLR8 DMXL1 TCF3 DCAF13 RCAN1 ESYT1 CPD VPS54 DCAF10 PAFAH1B1 AKAP13 | 7.84e-05 | 477 | 227 | 14 | M40930 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | MAP1A NCKAP1 MATR3 RNF19B INSM1 TOGARAM1 BCL9 WAC KIF3B PTPRJ SCAPER KIF5C PRKAG2 MTUS2 RABGGTB AHCTF1 PPM1E CPD DHRS7 PAFAH1B1 EIF4G3 | 8.22e-05 | 946 | 227 | 21 | M39169 |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 8.81e-05 | 162 | 227 | 8 | M6847 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 9.56e-05 | 210 | 227 | 9 | MM958 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP | 1.09e-04 | 167 | 227 | 8 | M365 | |
| Coexpression | LEE_AGING_CEREBELLUM_UP | 1.11e-04 | 87 | 227 | 6 | MM1023 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.28e-04 | 171 | 227 | 8 | M39234 | |
| Coexpression | FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP | 1.34e-04 | 90 | 227 | 6 | M48360 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | CYP1A1 ADGRV1 SLIT2 CSRNP1 UBP1 KLF5 CCSER1 ANK3 SEMA7A RCAN1 VPS54 SKIL ABLIM3 CTNND2 | 1.40e-04 | 504 | 227 | 14 | M2157 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | PTPRJ SCAPER OSBPL10 STK39 CCSER1 UBR2 TCF12 ANK3 VPS54 SIK3 EIF4G3 VPS13B | 5.36e-10 | 199 | 228 | 12 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | NCKAP1 INSM1 WAC KIF5C WNK2 RALGDS ANK3 ABLIM3 CELSR2 PAFAH1B1 PLXNA4 EIF4G3 | 5.67e-10 | 200 | 228 | 12 | c92e4fc0442404481fcac623d691dae6215b852d |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | MAP9 DAG1 ADGRV1 BCL9 CPD FRYL AKAP9 DCAF10 SMARCC1 PUM1 VPS13B | 5.14e-09 | 193 | 228 | 11 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADGRV1 PTPRJ KLF5 STK39 WNK2 DOP1B CCSER1 ANK3 MUC16 CPD CLINT1 | 7.45e-09 | 200 | 228 | 11 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | ADGRV1 SHC3 DUOX1 FAT1 KLF5 PITPNM2 ANK3 CACHD1 AKAP13 RAI14 | 1.28e-08 | 163 | 228 | 10 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.50e-08 | 190 | 228 | 10 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | SLIT2 PTPRJ SCAPER OSBPL10 CCSER1 TCF12 ANK3 SIK3 AKAP13 VPS13B | 6.07e-08 | 192 | 228 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.69e-08 | 194 | 228 | 10 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | DDAH1 ADGRV1 CHI3L2 FREM2 DUOX1 TC2N KLF5 ANK3 CCDC141 RAI14 | 8.89e-08 | 200 | 228 | 10 | c2bde99b3bc7a8740441c1a0c1394892b940b857 |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | DDAH1 ADGRV1 CHI3L2 FREM2 DUOX1 TC2N KLF5 ANK3 CCDC141 RAI14 | 8.89e-08 | 200 | 228 | 10 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | DDAH1 ADGRV1 CHI3L2 FREM2 DUOX1 TC2N KLF5 ANK3 CCDC141 RAI14 | 8.89e-08 | 200 | 228 | 10 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.97e-07 | 189 | 228 | 9 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.97e-07 | 189 | 228 | 9 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.52e-07 | 191 | 228 | 9 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.52e-07 | 191 | 228 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 6.52e-07 | 191 | 228 | 9 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 6.81e-07 | 192 | 228 | 9 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.43e-07 | 194 | 228 | 9 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-07 | 196 | 228 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-07 | 199 | 228 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-07 | 199 | 228 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-06 | 151 | 228 | 8 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 1.20e-06 | 152 | 228 | 8 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-06 | 163 | 228 | 8 | 3087224d3f16f5d3aecc3e1e4366220231afe31f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 2.78e-06 | 170 | 228 | 8 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-06 | 179 | 228 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-06 | 180 | 228 | 8 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-06 | 182 | 228 | 8 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.80e-06 | 183 | 228 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.00e-06 | 184 | 228 | 8 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 5.20e-06 | 185 | 228 | 8 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.41e-06 | 186 | 228 | 8 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.41e-06 | 186 | 228 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-06 | 188 | 228 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 6.33e-06 | 190 | 228 | 8 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.33e-06 | 190 | 228 | 8 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.33e-06 | 190 | 228 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.33e-06 | 190 | 228 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 6.33e-06 | 190 | 228 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.58e-06 | 191 | 228 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 6.58e-06 | 191 | 228 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 6.58e-06 | 191 | 228 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 6.58e-06 | 191 | 228 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.83e-06 | 192 | 228 | 8 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 6.83e-06 | 192 | 228 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.83e-06 | 192 | 228 | 8 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.10e-06 | 193 | 228 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.10e-06 | 193 | 228 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.10e-06 | 193 | 228 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 7.10e-06 | 193 | 228 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.10e-06 | 193 | 228 | 8 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.37e-06 | 194 | 228 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.37e-06 | 194 | 228 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.37e-06 | 194 | 228 | 8 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-06 | 195 | 228 | 8 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.65e-06 | 195 | 228 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.65e-06 | 195 | 228 | 8 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 196 | 228 | 8 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 7.94e-06 | 196 | 228 | 8 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 7.94e-06 | 196 | 228 | 8 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.24e-06 | 197 | 228 | 8 | c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1 | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.55e-06 | 198 | 228 | 8 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.55e-06 | 198 | 228 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-06 | 199 | 228 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | 8.87e-06 | 199 | 228 | 8 | 1e738219784a446ee8b0ddeb408e0050e1929e60 | |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | 8.87e-06 | 199 | 228 | 8 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.87e-06 | 199 | 228 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.20e-06 | 200 | 228 | 8 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.20e-06 | 200 | 228 | 8 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.20e-06 | 200 | 228 | 8 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.20e-06 | 200 | 228 | 8 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.20e-06 | 200 | 228 | 8 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.20e-06 | 200 | 228 | 8 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.20e-06 | 200 | 228 | 8 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.20e-06 | 200 | 228 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.20e-06 | 200 | 228 | 8 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.20e-06 | 200 | 228 | 8 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.20e-06 | 200 | 228 | 8 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.67e-05 | 157 | 228 | 7 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 1.97e-05 | 161 | 228 | 7 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 170 | 228 | 7 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 170 | 228 | 7 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-05 | 171 | 228 | 7 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-05 | 171 | 228 | 7 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.12e-05 | 173 | 228 | 7 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 3.75e-05 | 178 | 228 | 7 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 178 | 228 | 7 | 742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.88e-05 | 179 | 228 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.02e-05 | 180 | 228 | 7 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | severe-CD8+_T_naive|severe / disease stage, cell group and cell class | 4.02e-05 | 180 | 228 | 7 | 94fe530367b170777f4051a4034cff06d80dbb83 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 4.17e-05 | 181 | 228 | 7 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | severe-CD8+_T_naive|World / disease stage, cell group and cell class | 4.17e-05 | 181 | 228 | 7 | 69eeeb7f326e230b07495d557f708fbe3312ac0a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.17e-05 | 181 | 228 | 7 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 182 | 228 | 7 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 182 | 228 | 7 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.31e-05 | 182 | 228 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 184 | 228 | 7 | da8d6e7944eb35e6cbea2feb7cbc2894787d723f | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.62e-05 | 184 | 228 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 184 | 228 | 7 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 184 | 228 | 7 | fa4915b0498f3069fd5ef497286445528f75187e | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A | NCKAP1 RNF19B KLF5 KIF5C PRKAG2 RABGGTB DOP1B TCF12 DYNC2H1 VPS54 AKAP9 P2RY6 SEPTIN11 | 8.24e-08 | 195 | 226 | 13 | 5297_UP |
| Disease | creatinine measurement | CYP1A1 PLAC1 ADGRV1 MMP24 DUOX1 ACSM3 ALMS1 PTPRJ PRKAG2 ABCC10 TFEB TBX4 TCF12 SEMA7A FAM227B ABLIM3 SH2B2 CELSR2 PCDHGB4 PNPLA7 REPS2 CDH13 | 6.03e-06 | 995 | 220 | 22 | EFO_0004518 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.21e-05 | 49 | 220 | 5 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 1.65e-04 | 3 | 220 | 2 | DOID:0060488 (implicated_via_orthology) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.64e-04 | 118 | 220 | 6 | EFO_0001645, EFO_0004629 | |
| Disease | peripheral arterial disease | 7.10e-04 | 54 | 220 | 4 | EFO_0004265 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 8.14e-04 | 6 | 220 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | hydrocephalus (is_implicated_in) | 8.14e-04 | 6 | 220 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | Neointima Formation | 8.14e-04 | 6 | 220 | 2 | C2936381 | |
| Disease | Neointima | 8.14e-04 | 6 | 220 | 2 | C2936380 | |
| Disease | Colorectal Carcinoma | F5 WAC NDST3 FAT1 KCNA10 KLF5 RALGDS TCF3 NRAS PPM1E CDH22 AKAP9 CTNND2 GABRA6 | 8.57e-04 | 702 | 220 | 14 | C0009402 |
| Disease | photoreceptor cell layer thickness measurement | 8.78e-04 | 148 | 220 | 6 | EFO_0803370 | |
| Disease | calcium measurement | MAP1A WDR81 TC2N PRKAG2 ABCC10 PITPNM2 NRAS RCAN1 CARS1 SIK3 MTMR7 CELSR2 POLQ | 9.34e-04 | 628 | 220 | 13 | EFO_0004838 |
| Disease | Adenocarcinoma of lung (disorder) | 9.38e-04 | 206 | 220 | 7 | C0152013 | |
| Disease | Schizophrenia | MAG INPP5A SRD5A2 BCL9 ERVW-1 PCDH17 TYR NDST3 KLF5 ANK3 GRIA2 GRIN2B PAFAH1B1 SEPTIN11 CTNND2 GABRA6 | 1.03e-03 | 883 | 220 | 16 | C0036341 |
| Disease | obesity (implicated_via_orthology) | 1.20e-03 | 215 | 220 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | D dimer measurement | 1.43e-03 | 30 | 220 | 3 | EFO_0004507 | |
| Disease | coronary artery disease, factor VII measurement | 1.49e-03 | 111 | 220 | 5 | EFO_0001645, EFO_0004619 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.50e-03 | 8 | 220 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | hypospadias (is_implicated_in) | 1.50e-03 | 8 | 220 | 2 | DOID:10892 (is_implicated_in) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.50e-03 | 8 | 220 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | multiple myeloma | 1.55e-03 | 112 | 220 | 5 | EFO_0001378 | |
| Disease | hearing loss | 1.60e-03 | 67 | 220 | 4 | EFO_0004238 | |
| Disease | factor VIII measurement, coronary artery disease | 1.61e-03 | 113 | 220 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | serum albumin measurement | MAP1A WDR81 ADGRV1 PRR12 PTPRJ UBP1 DOCK3 TFEB NRAS DOK2 SIK3 SMARCC1 | 1.74e-03 | 592 | 220 | 12 | EFO_0004535 |
| Disease | factor XI measurement, coronary artery disease | 1.74e-03 | 115 | 220 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | Complement deficiency disease | 1.89e-03 | 33 | 220 | 3 | C0272242 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.92e-03 | 9 | 220 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.92e-03 | 9 | 220 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | glycogen storage disease (is_implicated_in) | 1.92e-03 | 9 | 220 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | factor VIII measurement, venous thromboembolism | 2.06e-03 | 34 | 220 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | respiratory symptom measurement, COVID-19 | 2.30e-03 | 74 | 220 | 4 | EFO_0007939, MONDO_0100096 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 2.39e-03 | 10 | 220 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 2.39e-03 | 10 | 220 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | theophylline measurement | 2.39e-03 | 10 | 220 | 2 | EFO_0021180 | |
| Disease | 2-ketocaprylate measurement | 2.39e-03 | 10 | 220 | 2 | EFO_0800110 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 2.43e-03 | 36 | 220 | 3 | EFO_0022257 | |
| Disease | schizophrenia (is_implicated_in) | 2.79e-03 | 78 | 220 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | meningitis | 2.91e-03 | 11 | 220 | 2 | MONDO_0021108 | |
| Disease | glycerophosphorylcholine measurement | 2.91e-03 | 11 | 220 | 2 | EFO_0020018 | |
| Disease | macula measurement | 3.03e-03 | 189 | 220 | 6 | EFO_0008375 | |
| Disease | Graves' disease (is_implicated_in) | 3.07e-03 | 39 | 220 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | ciliopathy (implicated_via_orthology) | 3.30e-03 | 40 | 220 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | motor neuron disease (implicated_via_orthology) | 3.48e-03 | 12 | 220 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 3.79e-03 | 42 | 220 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 4.05e-03 | 43 | 220 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | triglycerides in large LDL measurement | 4.05e-03 | 43 | 220 | 3 | EFO_0022319 | |
| Disease | lipid measurement, lipoprotein measurement | 4.66e-03 | 90 | 220 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.72e-03 | 145 | 220 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | actinic keratosis | 4.75e-03 | 14 | 220 | 2 | EFO_0002496 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 4.75e-03 | 14 | 220 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | precuneus cortex volume measurement | 4.75e-03 | 14 | 220 | 2 | EFO_0010326 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 4.75e-03 | 14 | 220 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | triacylglycerol 54:4 measurement | 4.90e-03 | 46 | 220 | 3 | EFO_0010422 | |
| Disease | amino acid measurement | SETX NDST3 SLIT2 ALMS1 PTPRJ STK39 C5 MTUS2 WNK2 CCSER1 TCF12 GRIN2B | 5.15e-03 | 678 | 220 | 12 | EFO_0005134 |
| Disease | Down syndrome (implicated_via_orthology) | 5.45e-03 | 15 | 220 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | response to olanzapine | 5.45e-03 | 15 | 220 | 2 | GO_0097333 | |
| Disease | response to statin, LDL cholesterol change measurement | 5.45e-03 | 15 | 220 | 2 | EFO_0007804, GO_0036273 | |
| Disease | N-acetylmethionine measurement | 5.45e-03 | 15 | 220 | 2 | EFO_0021427 | |
| Disease | diet measurement | B3GALT1 CYP1A1 TDRD15 INSM1 KIAA1143 PCDH17 PTK6 TYR MMP24 ACSM3 ANK3 CDH22 CELSR2 PCDHGB4 CTNND2 CDH13 | 5.60e-03 | 1049 | 220 | 16 | EFO_0008111 |
| Disease | Seizures | 6.04e-03 | 218 | 220 | 6 | C0036572 | |
| Disease | fibrinogen measurement, coronary artery disease | 6.07e-03 | 154 | 220 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | pneumonia (is_implicated_in) | 6.20e-03 | 16 | 220 | 2 | DOID:552 (is_implicated_in) | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 6.20e-03 | 16 | 220 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | central nervous system disease (implicated_via_orthology) | 6.20e-03 | 16 | 220 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | uric acid measurement | INPP5A ADGRV1 F5 QRICH2 PRKAG2 INTS7 DYNC2H1 XPNPEP2 MYOF AKAP13 RAI14 | 6.36e-03 | 610 | 220 | 11 | EFO_0004761 |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 6.54e-03 | 51 | 220 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 6.54e-03 | 51 | 220 | 3 | EFO_0022242 | |
| Disease | visual perception measurement | 6.73e-03 | 223 | 220 | 6 | EFO_0009700 | |
| Disease | Antibody Deficiency Syndrome | 6.99e-03 | 17 | 220 | 2 | C0003257 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 6.99e-03 | 17 | 220 | 2 | EFO_0022232 | |
| Disease | urate measurement, bone density | INPP5A RC3H1 SHC3 PCDH17 GPR149 AHCTF1 HELZ2 PLXNA4 CTNND2 CDH13 GABRA6 | 7.07e-03 | 619 | 220 | 11 | EFO_0003923, EFO_0004531 |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 7.28e-03 | 53 | 220 | 3 | EFO_0022258 | |
| Disease | Endometrioma | 7.29e-03 | 161 | 220 | 5 | C0269102 | |
| Disease | Endometriosis | 7.29e-03 | 161 | 220 | 5 | C0014175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSDPHAVAGALKSYL | 346 | Q6ZT62 | |
| AKTVAHTEGYPSFLS | 1386 | O60241 | |
| NSLKSPALSGHSIDY | 71 | Q6ZSB3 | |
| RLATKSHYSSTGPEF | 366 | Q96M60 | |
| TKHLSPYATLTVGDS | 816 | Q9BSJ8 | |
| PYATLTVGDSSHKTK | 821 | Q9BSJ8 | |
| SEKELYATPATLHNG | 291 | Q52LR7 | |
| HYLADSDPLISKSAS | 571 | O94929 | |
| THYAPSKAAALAAAL | 221 | Q9UGJ0 | |
| SYSQSSLIHLVGPSD | 146 | Q6ZUV0 | |
| KEGSSIPELAHSDAY | 2881 | Q99996 | |
| ISLYESAAKLGIHPS | 481 | O94986 | |
| TALYAAGSKSHKPLN | 606 | P0C0L5 | |
| SYTGSKPFSHLTVAR | 31 | Q9Y5Z6 | |
| KGTATPELHTATDYR | 811 | Q12802 | |
| TTDITIKASDHPYGL | 1691 | Q8WXG9 | |
| GKPVSLSSSYFHREK | 2086 | Q8TCU4 | |
| EASYTAHLTSPLTAI | 111 | Q5VU97 | |
| STYKHISPLDASGQR | 511 | B6SEH9 | |
| SLVPKAAADSTSHSY | 426 | Q9BXJ7 | |
| IPTYGHSFTLASAET | 266 | Q15782 | |
| HPSYLFTLSVKTTRG | 111 | Q9NSE2 | |
| KYDPSSAKIISNSGH | 51 | Q8N1Q1 | |
| TSHGYEANPAKVLAS | 431 | Q9C0I3 | |
| LHSTSRSGKSQPSYI | 2666 | Q9HCU4 | |
| YGPSSTATVHITVLD | 456 | P55290 | |
| SVPLSIGYCASKHAL | 196 | Q9Y394 | |
| SPGHDYSFSSLSKIK | 951 | Q6DHV5 | |
| IKPSAGHLSSSSIYP | 966 | Q9Y485 | |
| YIASHTAEESLSAGP | 2551 | Q9Y485 | |
| DSGATVLAYAPKHQL | 2886 | Q9Y485 | |
| ELERSTGYHLDSKTP | 896 | Q96F81 | |
| YATLSPTKRLVHASE | 356 | Q9UQB3 | |
| HVSAVLDVDYSPTGK | 281 | Q9NV06 | |
| ESNSEHPLGTAITKY | 1081 | Q04656 | |
| KRVAASTTKLHSPGY | 956 | Q5JR59 | |
| PSISKGAFYATIIHD | 246 | O95803 | |
| YDSSLKPGKIDHLSS | 516 | Q5TC82 | |
| GEKYELHAATDTTPS | 196 | P53805 | |
| ELGYGDHKPKSSTAA | 461 | Q9P258 | |
| HELAKSYGIPFIETS | 131 | P01111 | |
| PAESVDSSGKTALHY | 111 | Q9P0K7 | |
| YTEKEGPLLSDSHVA | 361 | P13056 | |
| TVSYSILPSHIGDVS | 506 | O14917 | |
| RTHLAYALDLGSSPV | 566 | Q9H1K0 | |
| LPSTDQHGLVSVSAY | 291 | Q9H0J4 | |
| IPHSTTRDTSLKGFY | 386 | P04798 | |
| KISGSVTSAKPGYHD | 726 | Q9UHI8 | |
| LGSEPELAHLYSTKS | 596 | Q86VS3 | |
| FYHKGIASLTAASTP | 596 | Q9NVH2 | |
| RLTGPSGLSSYHLKT | 421 | Q8IWB1 | |
| LDFHKTAPYVVTGSV | 386 | P43034 | |
| KSYHLTLTALDFGAP | 206 | Q9UN71 | |
| AHLDSGPSTAKLDYS | 371 | P22736 | |
| ITAIKYIPHSSATES | 556 | Q6NSI4 | |
| LALGTTEYHPFTLTS | 1311 | Q9NRD9 | |
| EISYINAHATSTPLG | 341 | Q9NWU1 | |
| AHPAYKLSIRATDSL | 2246 | Q14517 | |
| LLPYDSRASALHSAK | 91 | Q9Y5R2 | |
| LYSSVSIHSEPSKAT | 10116 | Q8WXI7 | |
| GSLTLSPLYSHLADT | 1096 | Q5T3U5 | |
| SPLYSHLADTLAGLS | 1101 | Q5T3U5 | |
| HAGSLTNLAKYPAST | 311 | O00567 | |
| EASHGPIKAYAVILT | 841 | Q12913 | |
| NELYSSAVTVGPHKE | 136 | O60496 | |
| SLTTPAGATEHVSYI | 721 | P78559 | |
| LAYLPSGSSAHLVDE | 951 | Q66K74 | |
| SNLPHSGYSDSAVLK | 501 | P43243 | |
| PSTTTSSHYLGTLKV | 391 | Q49MG5 | |
| SYSHSDLGKRPTKDS | 596 | P20916 | |
| PSKTIDLGAAAHYTG | 281 | Q14677 | |
| YVPKSATAHIIVGSS | 166 | Q9Y216 | |
| YEIFKGTLKPDSTHS | 386 | P16233 | |
| LGPHYTSQKVSDSLD | 516 | Q96S65 | |
| VKHPSDEKYSGLTAS | 101 | Q96AT1 | |
| STHASKTCKPALGYS | 441 | Q9NR71 | |
| SLVTHSLPYFGKSLG | 1521 | Q9Y3R5 | |
| PKTIIGYQAHADTAT | 216 | A6NMX2 | |
| ESLLSYLTGSFPSLH | 2291 | Q2LD37 | |
| THYGFLTDATKNPEI | 2591 | Q5SZK8 | |
| SIGVTLYHAATGSLP | 206 | Q14164 | |
| KGFSPYHSESQLASL | 301 | A6NKD9 | |
| PLDTDKGVHYISVSA | 121 | Q14118 | |
| VSSLATGLKPRYHFA | 181 | Q69YN2 | |
| PGAHTTTIKYTSALT | 286 | P42262 | |
| SLSDSFHIYIGAPKQ | 341 | P17181 | |
| STAHRGSALPLAIKY | 1701 | Q9HCM2 | |
| SPDLLLDSSGSHLYV | 446 | Q9ULL4 | |
| ETSPSVYSGIRHKAL | 196 | Q14642 | |
| LTESKSTVPHAYATA | 291 | O00330 | |
| VSVAHALSLPAESYG | 16 | Q9BVG4 | |
| KYEAAGTLVTLSSAP | 261 | P53618 | |
| HDLDLTKSLEVGSYP | 326 | Q5QP82 | |
| YSLLSHIDLSAAPAK | 2206 | O94915 | |
| KALASIYSPDHTSSS | 341 | Q99081 | |
| SHHLSALVTPAGKSY | 166 | Q9UJQ1 | |
| YSKIEALLGSAGHTT | 196 | Q9H3U5 | |
| LSISARHSLPKVSYA | 286 | Q16445 | |
| SLSTSIKYSHPGETD | 481 | Q9UKK3 | |
| RPLSSYVSVHAESGK | 501 | Q9Y5H7 | |
| HTFADSYITVLPKGT | 1091 | Q9BZ72 | |
| DIITGHAAPYKTVSV | 221 | Q6ZV29 | |
| YTSVSKASLGLADHR | 496 | Q9Y2A7 | |
| NKSTLVEYSGVSHEP | 201 | Q16827 | |
| PEALSRGHYSTKSDV | 356 | Q13882 | |
| LYKRTSSSLTPIGHS | 716 | Q14671 | |
| SDLSAHYIPKETDGT | 176 | Q8WY54 | |
| HAPTGKTLSLSTYEV | 561 | Q86SP6 | |
| SSTIFLYVRPGKAHS | 251 | Q8N148 | |
| SASIGHDPHLLYTLS | 86 | P53611 | |
| TYSVDKHVPDSGATA | 101 | P10696 | |
| KHVPDSGATATAYLC | 106 | P10696 | |
| HVTDYKTSESTGSLP | 171 | O95456 | |
| STNHETAFSKLPGDY | 56 | Q16322 | |
| EGTLFVYTRSASPKH | 56 | Q8IZD4 | |
| LLIHESCKAYGATPS | 2856 | Q8NCM8 | |
| KTYFSHLDLSPGSSQ | 41 | P09105 | |
| ASKIGHSYSLDSQPA | 846 | Q9BX69 | |
| EPVSSSLSLHISSYG | 1236 | Q6ZP82 | |
| AKYSAPSASHGLIIS | 366 | Q8IZD9 | |
| EGFPSHLLYSITTVS | 266 | Q6ZTQ4 | |
| STPLYHDAIKTVASS | 1021 | O00512 | |
| GKVYHPTHLGSATLS | 606 | O75417 | |
| SAYALSLGDKTHPQF | 1191 | P01031 | |
| PEHKATGIYSKTSDD | 271 | O75976 | |
| LSSGISESSHFIPYV | 836 | A2RUB6 | |
| NAATTSGYTPLHLSA | 526 | Q12955 | |
| DLYSHNKASPSGLKS | 976 | Q9P203 | |
| DLYITFSGHLVKPAA | 236 | P60827 | |
| LYSELKKTHPDDSAG | 691 | Q96P31 | |
| PYLSSGDIADALSVH | 696 | Q12967 | |
| PATTLTLSGHYATIS | 56 | P01854 | |
| CHSLSLYSATKGSPH | 136 | Q6PJG2 | |
| PKEICVGSSDTSYHS | 46 | Q8NEP3 | |
| KFLSYALIDPTHEGT | 91 | Q92538 | |
| KSSSPAVVASYLHEV | 791 | Q5T7N3 | |
| YKSFSSLGCDLPQTH | 16 | P32881 | |
| TGTEPLYVGKIHSDS | 76 | Q9UJ99 | |
| LAIERAKPYHLSTSS | 1011 | Q8WYP5 | |
| THKPYLVTFDLTDSG | 106 | Q6IAN0 | |
| YLPELSHQKSSEAGE | 4116 | Q8NDH2 | |
| ESLHGYTLSNSKGPV | 4991 | Q8NDH2 | |
| SSSRKYTELPHGAIS | 136 | Q9H773 | |
| YSHPGASVDLTIFSL | 136 | P00395 | |
| EALTPLAYASHGTRL | 676 | Q9BYK8 | |
| FPELSNKGSYSLSHV | 251 | P07686 | |
| YLSSVLPHDAKDTVA | 606 | P51530 | |
| LSSGRHANTDYAPKL | 771 | Q9BY12 | |
| YGTVESAHLAASTPV | 196 | O43432 | |
| SSSHLPAYLVAAFAK | 356 | Q9BVI4 | |
| YAVSTVPVADGLHLK | 161 | O94760 | |
| TALYAAGSKSHKPLN | 606 | P0C0L4 | |
| GSYILTKAALPAHSF | 451 | O14772 | |
| STHVALGAYAPLTKH | 321 | Q14623 | |
| HGLSIDGYVLPSSTT | 1096 | P46019 | |
| HITKTAYLAVRSTPG | 256 | Q15077 | |
| ATFYSSPGLTRHINK | 476 | Q01101 | |
| SGKTPHLYSHSILGL | 556 | Q92918 | |
| ASLLGADTPVKTYHS | 596 | Q75VX8 | |
| TEIHYSSKGTPSKFV | 96 | Q9HBJ0 | |
| KTASELKILYGHSGP | 531 | Q15542 | |
| PTYEHIQTALSSKDG | 501 | Q10713 | |
| HVKSAAVALGPAASY | 781 | P84550 | |
| NPDLFITGSYDHTVK | 176 | Q8TED0 | |
| TSYAVDGLFSSHPSK | 96 | Q765I0 | |
| LTRVHGTSSPYKGLD | 136 | Q9UQF0 | |
| GTSSPYKGLDLSKLH | 141 | Q9UQF0 | |
| TEAGKHYVASTEPQL | 211 | Q9BZY9 | |
| LSETYGNKFAAHISP | 96 | P19484 | |
| KPSHYQLVSGSSTED | 596 | Q6ZMZ0 | |
| ASSEKHSYGKLVPEA | 276 | P49589 | |
| SLSSYAVHIISPGEA | 376 | Q8IWB6 | |
| LYFIAPTGHSLKSLD | 151 | Q9NVA2 | |
| SSLDKVVLSDAYAHP | 21 | Q15628 | |
| AHSSGKLQKTVSYPD | 441 | P12757 | |
| KVELSSSSQHGPSYD | 111 | Q8N9U0 | |
| LVASGLATYSKDSPH | 1906 | B5MCY1 | |
| LATYSKDSPHLDAIT | 1911 | B5MCY1 | |
| KLSEGASYLDHTFPA | 121 | P12259 | |
| ISALAEGTKTHVPYR | 266 | O60282 | |
| ENLPYLSDKDGSSSH | 406 | Q6ZQX7 | |
| PNTLTDKFYVHSEGT | 466 | Q9H3W5 | |
| SSIKEKYPSHSFIGE | 56 | P29218 | |
| GSSDIYSTPEGKLHV | 401 | Q92529 | |
| ASLYHTPSDSKEITL | 2506 | Q7Z333 | |
| YGHRPLSKQLSADSA | 856 | Q9Y2K2 | |
| QALKYSSKSHPSSGD | 26 | Q9BTA9 | |
| AKASLVYGSSRTSHP | 26 | Q9ULL5 | |
| YVHADAPTNKTLAGL | 66 | Q92922 | |
| PSYAIFGSKTIHLTG | 331 | P51688 | |
| AKTGYSATVIFHTKP | 616 | Q9BXB5 | |
| QKADHTLSSLEPAYS | 221 | Q5VW32 | |
| GLFTHYVDNPSKTAS | 436 | Q53FZ2 | |
| LPTVSHSGFLYKTAS | 741 | Q96P48 | |
| SHKALDADIYSAIPT | 41 | Q8N999 | |
| LSGTEFSAIPHVKYL | 521 | Q9NR97 | |
| HPSKKGASSAYLENS | 86 | Q05086 | |
| DYGKISPLSVHTKTG | 236 | Q13360 | |
| VPLSHGYSKLRSSAE | 206 | Q8NFH8 | |
| ALGKALASIYSPDHS | 331 | P15923 | |
| ALVDGKSTHIPYRDS | 281 | O15066 | |
| ALIALKKYHSGPASS | 151 | P38935 | |
| KLDSTSSFPILGHSY | 1036 | Q6ZQQ2 | |
| AVHSLSVIPDSGYIS | 276 | Q9Y4K3 | |
| YVFLDPLAGAVTKTH | 186 | Q6VEQ5 | |
| YVFLDPLAGAVTKTH | 186 | A8K0Z3 | |
| PYRTLSGHTAKITSV | 631 | Q8TEQ6 | |
| SLADLSPSTHYTAKI | 1941 | P24821 | |
| VLAFGAKPDSTLHTY | 351 | Q6NUQ4 | |
| AKHTISSDYVIPIGT | 141 | P14679 | |
| SGYGKHTESLKPAAT | 31 | P31213 | |
| FRTSSLKGYHSSLPN | 346 | O75326 | |
| LADTSALKAAPYGHS | 101 | O14492 | |
| ALKAAPYGHSRSSED | 106 | O14492 | |
| TGSHPASAIYSVETI | 1221 | O94813 | |
| AIGYSSSKLTLHVGD | 141 | P19623 | |
| VTLSVDKYSFPSGHA | 201 | Q8IY26 | |
| ATSPAVKLHDETLTY | 71 | Q9NZI7 | |
| GLSSYTPKHSVAFSK | 656 | Q4KMQ1 | |
| YAISSAGLTHALAKA | 126 | O14904 | |
| ASLKLYIASDHTPLS | 3601 | Q7Z7G8 | |
| EPVKRDSLASHYSGV | 231 | Q86YA3 | |
| KLYATGSRDPSTEVH | 216 | Q9NYW2 | |
| VPKGSYAFHTLEKSL | 211 | P0CG31 | |
| AGIAHPSALSSVYLL | 211 | Q92508 | |
| KRSYLEAPSSVGEDH | 351 | P57082 | |
| ASGLNAALAHYSPTK | 421 | O43895 | |
| STPHSSLVGFISLLY | 386 | Q9Y4F4 | |
| LLYQEHVPTSSASAG | 1596 | Q9Y3S1 | |
| LAVSPSGDYVVSSSH | 681 | Q9UNX4 | |
| KAASVYLAVHFPGSS | 1201 | Q5JPB2 | |
| ENAIGDPYKTHISSA | 341 | Q9NX45 | |
| DPYKTHISSAALSLN | 346 | Q9NX45 | |
| ITAIELATGAAPYHK | 261 | Q9UEW8 | |
| TPDYGKRFSSEITHK | 726 | Q8IWV8 | |
| SRSDPSAKYHGILQA | 51 | Q9HC21 | |
| HNLYSASAGSLPAVK | 26 | Q8N228 | |
| KTLASPADTAGFLHS | 326 | O75385 | |
| KSASDPIHTFDLYGS | 1866 | Q562E7 | |
| GDSHSLYVAPSLVTD | 46 | Q9P1Q0 | |
| PSYAATIASKLAIHN | 326 | Q13887 | |
| TTYLHLSKIAASGGE | 456 | Q9NZM1 | |
| GLPSSKHSQLSDLYG | 1026 | Q13224 |